Investment & deals

The Global Financing Facility (GFF) has secured US$1bn in new funding commitments to improve maternal and child health and reduce preventable deaths. The funding, announced at the close of its 2026 investment round, will support healthcare for women, children and adolescents, particularly in low- and middle-income countries. It will help countries improve access to essential [...]

Helium Health has secured a US$2.5m grant to deploy AI-powered tools aimed at improving maternal healthcare across four Nigerian states. The funding will support the rollout of clinical AI technology in primary maternal healthcare services across Lagos, Delta, Kano and Oyo, with Lagos serving as the main operational launch site. The initiative will use the [...]

Nayara has raised pre-seed funding to expand its AI patient support platform, designed to help people manage their healthcare needs between clinical appointments. The UK-based healthtech company develops AI-powered companions for hospitals, healthcare systems and medical technology companies. Its technology answers routine questions, provides personalised guidance and emotional support, and proactively checks in with patients. [...]

Fertifa has agreed to acquire women's health technology company Tuune, expanding its employee healthcare services into personalised hormonal care. Tuune develops regulated clinical software that assesses more than 70 symptoms alongside an individual's medical history to support clinical decisions about contraception and menopause. The deal continues Fertifa's expansion beyond its original focus on fertility benefits. [...]

Aspen Pharmacare has completed the €197m sale of Ovestin's European rights to privately owned Ennogen Healthcare International. Aspen received the payment on 3 November after Ennogen secured unconditional funding for the acquisition. Ennogen will also pay €4m for existing stocks of the product. Aspen will retain a manufacturing and supply role under a separate 10-year [...]

A £100,000 funding call has opened for women's and cardiovascular health projects across Wessex, with £50,000 available for each area. The scheme will support research, patient and public involvement and engagement (PPIE), workshops and other initiatives aimed at improving health outcomes in local communities. Most awards are expected to be below £5,000, although applications for [...]

Women's health pharmaceutical company Theramex is set to be acquired in a deal reportedly worth €2.6bn, with completion expected in the first half of 2027. The London-headquartered business provides treatments for menopause, osteoporosis, contraception, uterine health and fertility. The transaction remains subject to regulatory approval. Financial terms have not been formally disclosed. Theramex operates in [...]

Wearable breast pump maker Willow has acquired Swehl and Momtech to expand its breastfeeding education, support and feeding technology offerings. The US company said the deals would bring together products, educational resources and community support that have traditionally operated separately within maternal healthcare. Swehl is a maternal wellness and breastfeeding platform. Its acquisition will help [...]

Swiss pharmaceutical company Ferring has agreed to acquire US fertility start-up Gameto in a deal worth up to US$1.38bn, expanding its fertility treatment business. The final value will depend on the achievement of development, regulatory and commercial milestones, according to the companies. The acquisition will bring Gameto's reproductive health technologies into Ferring's fertility portfolio, with [...]

The Victorian government has committed a further A$10m to the Alice Anderson Fund, doubling its initial 2021 investment in women-founded startups. The funding will provide capital, business networks and support to help more women entrepreneurs grow their companies. The fund aims to address the gender gap in Australian venture capital, where female founders receive a [...]